Memphasys Limited (ASX: MEM)

Sector: Health Care

Market cap: A$12M (as of 2 Nov 2026)

Memphasys Limited (ASX:MEM) specialises in biological separations for commercial applications. The Company's patented membrane processes enable the selection of high value substances or contaminants from the fluid in which they are contained.

Data as of 2 Nov 2026.

Recent capital raises

Date	Type	Amount	Price	Discount	Source
18 June 2026	Placement	$1.2M	$0.01	0%	Filing ↗
6 Feb 2026	Placement	$0.8M	$0.01	28.6% discount	Filing ↗
30 Dec 2025	Placement	$0.579M	$0.00	—	Filing ↗
10 Oct 2025	Public offer	$1.12M	$0.00	—	Filing ↗
14 Apr 2025	Placement	$1.275M	$0.01	—	Filing ↗

Substantial holders — latest moves

Date	Holder	Move	Holding	Source
15 July 2026	Gowans Superfund	Entry	—	Filing ↗
23 Feb 2026	PETERS INVESTMENTS PTY LTD	Decrease	27.430% → 0.195%	Filing ↗
30 Sept 2025	MR ANDREW ERNEST GOODALL	Entry	?% → 14.507%	Filing ↗
18 Sept 2024	PETERS INVESTMENTS PTY LTD	Entry	?% → 18.098%	Filing ↗
30 Sept 2022	MR ANDREW ERNEST GOODALL	Decrease	23.36% → 17.76%	Filing ↗

Director trades — on-market

Date	Director	Trade	Source
30 Dec 2022	Andrew Goodall	Bought 1,400,000	Filing ↗
30 Dec 2022	Alison Coutts	Bought 392,500 shares (Alison Coutts Super Fund)	Filing ↗
29 Mar 2019	Andrew Goodall	Bought Direct: 496,843	Filing ↗

Cash and runway

Metric	Value	As of	Source
Cash	A$3M	30 Sept 2026	Filing ↗
Runway	3 quarters	30 Sept 2026	Filing ↗

Ask about MEM in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

Has MEM raised money in the last year, and at what discount?
What was MEM's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading MEM…